APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell Division Cycle 7 Related Protein Kinase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell Division Cycle 7 Related Protein Kinase Industry Growth and Trends Forecast to 2032

Report ID 173976260119 December 202593 pages

Choose your research edition.

Industry ResearchCell Division Cycle 7 Related Protein Kinase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Division Cycle 7 Related Protein Kinase Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Cell Division Cycle 7 Related Protein Kinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Division Cycle 7 Related Protein Kinase Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Division Cycle 7 Related Protein Kinase Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cell Division Cycle 7 Related Protein Kinase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell Division Cycle 7 Related Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell Division Cycle 7 Related Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Division Cycle 7 Related Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell Division Cycle 7 Related Protein Kinase include Millennium Pharmaceuticals Inc, Nerviano Medical Sciences Srl, Sierra Oncology Inc, Eli Lilly and Company and Takeda Pharmaceutical Company Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell Division Cycle 7 Related Protein Kinase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell Division Cycle 7 Related Protein Kinase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Division Cycle 7 Related Protein Kinase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Division Cycle 7 Related Protein Kinase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cell Division Cycle 7 Related Protein Kinase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell Division Cycle 7 Related Protein Kinase Market by Company

Millennium Pharmaceuticals Inc

Nerviano Medical Sciences Srl

Sierra Oncology Inc

Eli Lilly and Company

Takeda Pharmaceutical Company Ltd

Cell Division Cycle 7 Related Protein Kinase Segment by Type

LBS-007

LY-3143921

MSK-777

TAK-931

Others

Cell Division Cycle 7 Related Protein Kinase Segment by Application

Metastatic Breast Cancer

Ovarian Cancer

Colorectal Cancer

Acute Myelocytic Leukemia

Others

Cell Division Cycle 7 Related Protein Kinase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Division Cycle 7 Related Protein Kinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Division Cycle 7 Related Protein Kinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Division Cycle 7 Related Protein Kinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cell Division Cycle 7 Related Protein Kinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cell Division Cycle 7 Related Protein Kinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of LBS-007 Table 2. Major Company of LY-3143921 Table 3. Major Company of MSK-777 Table 4. Major Company of TAK-931 Table 5. Major Company of Others Table 6. Global Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 8. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type (2021-2026) Table 9. Global Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 10. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type (2021-2026) Table 11. Global Cell Division Cycle 7 Related Protein Kinase Price by Type (2021-2026) & (US$/Unit) Table 12. Global Cell Division Cycle 7 Related Protein Kinase Sales by Type (2027-2032) & (K Units) Table 13. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type (2027-2032) Table 14. Global Cell Division Cycle 7 Related Protein Kinase Sales by Type (2027-2032) & (US$ Million) Table 15. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type (2027-2032) Table 16. Global Cell Division Cycle 7 Related Protein Kinase Price by Type (2027-2032) & (US$/Unit) Table 17. North America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 18. North America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 20. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 24. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Type (2021-2026) & (US$ Million) Table 27. Cell Division Cycle 7 Related Protein Kinase Industry Trends Table 28. Cell Division Cycle 7 Related Protein Kinase Industry Drivers Table 29. Cell Division Cycle 7 Related Protein Kinase Industry Opportunities and Challenges Table 30. Cell Division Cycle 7 Related Protein Kinase Industry Restraints Table 31. Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Cell Division Cycle 7 Related Protein Kinase Revenue Market Share by Company (2021-2026) Table 33. Global Cell Division Cycle 7 Related Protein Kinase Sales by Company (2021-2026) & (K Units) Table 34. Global Cell Division Cycle 7 Related Protein Kinase Sales Share by Company (2021-2026) Table 35. Global Cell Division Cycle 7 Related Protein Kinase Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Cell Division Cycle 7 Related Protein Kinase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Cell Division Cycle 7 Related Protein Kinase Major Company Production Sites and Headquarters Table 38. Global Cell Division Cycle 7 Related Protein Kinase Company, Product Type & Application Table 39. Global Cell Division Cycle 7 Related Protein Kinase Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Cell Division Cycle 7 Related Protein Kinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Cell Division Cycle 7 Related Protein Kinase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Cell Division Cycle 7 Related Protein Kinase Sales by Region (2021-2026) & (K Units) Table 44. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Region (2021-2026) Table 45. Global Cell Division Cycle 7 Related Protein Kinase Sales by Region (2021-2026) & (US$ Million) Table 46. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Region (2021-2026) Table 47. Global Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Cell Division Cycle 7 Related Protein Kinase Sales by Region (2027-2032) & (K Units) Table 49. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Region (2027-2032) Table 50. Global Cell Division Cycle 7 Related Protein Kinase Sales by Region (2027-2032) & (US$ Million) Table 51. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Region (2027-2032) Table 52. Global Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 55. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application (2021-2026) Table 56. Global Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 57. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application (2021-2026) Table 58. Global Cell Division Cycle 7 Related Protein Kinase Price by Application (2021-2026) & (US$/Unit) Table 59. Global Cell Division Cycle 7 Related Protein Kinase Sales by Application (2027-2032) & (K Units) Table 60. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application (2027-2032) Table 61. Global Cell Division Cycle 7 Related Protein Kinase Sales by Application (2027-2032) & (US$ Million) Table 62. Global Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application (2027-2032) Table 63. Global Cell Division Cycle 7 Related Protein Kinase Price by Application (2027-2032) & (US$/Unit) Table 64. North America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 65. North America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 67. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 71. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Application (2021-2026) & (US$ Million) Table 74. Millennium Pharmaceuticals Inc Company Information Table 75. Millennium Pharmaceuticals Inc Business Overview Table 76. Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Product Portfolio Table 78. Millennium Pharmaceuticals Inc Recent Development Table 79. Nerviano Medical Sciences Srl Company Information Table 80. Nerviano Medical Sciences Srl Business Overview Table 81. Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Product Portfolio Table 83. Nerviano Medical Sciences Srl Recent Development Table 84. Sierra Oncology Inc Company Information Table 85. Sierra Oncology Inc Business Overview Table 86. Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Product Portfolio Table 88. Sierra Oncology Inc Recent Development Table 89. Eli Lilly and Company Company Information Table 90. Eli Lilly and Company Business Overview Table 91. Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Product Portfolio Table 93. Eli Lilly and Company Recent Development Table 94. Takeda Pharmaceutical Company Ltd Company Information Table 95. Takeda Pharmaceutical Company Ltd Business Overview Table 96. Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Product Portfolio Table 98. Takeda Pharmaceutical Company Ltd Recent Development Table 99. North America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026) & (K Units) Table 101. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share by Country (2021-2026) Table 102. North America Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share Forecast by Country (2027-2032) Table 104. North America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Cell Division Cycle 7 Related Protein Kinase Market Share by Country (2021-2026) Table 107. North America Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Cell Division Cycle 7 Related Protein Kinase Market Share Forecast by Country (2027-2032) Table 109. Europe Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026) & (K Units) Table 111. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share by Country (2021-2026) Table 112. Europe Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Cell Division Cycle 7 Related Protein Kinase Market Share by Country (2021-2026) Table 117. Europe Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Cell Division Cycle 7 Related Protein Kinase Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Share by Country (2021-2026) Table 127. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Share Forecast by Country (2027-2032) Table 129. Latin America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026) & (K Units) Table 131. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share by Country (2021-2026) Table 132. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Cell Division Cycle 7 Related Protein Kinase Market Share by Country (2021-2026) Table 137. Latin America Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Cell Division Cycle 7 Related Protein Kinase Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Share by Country (2021-2026) Table 147. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Cell Division Cycle 7 Related Protein Kinase Distributors List Table 152. Cell Division Cycle 7 Related Protein Kinase Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Cell Division Cycle 7 Related Protein Kinase Image Figure 2. Global Cell Division Cycle 7 Related Protein Kinase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Division Cycle 7 Related Protein Kinase Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell Division Cycle 7 Related Protein Kinase Sales (2021-2032) & (K Units) Figure 5. LBS-007 Image Figure 6. Global LBS-007 Sales YoY Growth (2021-2032) & (K Units) Figure 7. LY-3143921 Image Figure 8. Global LY-3143921 Sales YoY Growth (2021-2032) & (K Units) Figure 9. MSK-777 Image Figure 10. Global MSK-777 Sales YoY Growth (2021-2032) & (K Units) Figure 11. TAK-931 Image Figure 12. Global TAK-931 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Cell Division Cycle 7 Related Protein Kinase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Cell Division Cycle 7 Related Protein Kinase Market Share by Type 2025 VS 2032 Figure 17. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type in 2025 Figure 18. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type in 2025 Figure 19. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type in 2025 Figure 20. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type in 2025 Figure 23. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Cell Division Cycle 7 Related Protein Kinase Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Metastatic Breast Cancer Image Figure 30. Global Metastatic Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Ovarian Cancer Image Figure 32. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Colorectal Cancer Image Figure 34. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Acute Myelocytic Leukemia Image Figure 36. Global Acute Myelocytic Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Cell Division Cycle 7 Related Protein Kinase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Cell Division Cycle 7 Related Protein Kinase Market Share by Application 2025 VS 2032 Figure 41. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application in 2025 Figure 42. North America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application in 2025 Figure 43. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application in 2025 Figure 44. Europe Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application in 2025 Figure 47. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Market Share in Value by Application in 2025 Figure 51. North America Cell Division Cycle 7 Related Protein Kinase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Cell Division Cycle 7 Related Protein Kinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Cell Division Cycle 7 Related Protein Kinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Cell Division Cycle 7 Related Protein Kinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Cell Division Cycle 7 Related Protein Kinase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Cell Division Cycle 7 Related Protein Kinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Cell Division Cycle 7 Related Protein Kinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Cell Division Cycle 7 Related Protein Kinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Cell Division Cycle 7 Related Protein Kinase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Cell Division Cycle 7 Related Protein Kinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Cell Division Cycle 7 Related Protein Kinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Cell Division Cycle 7 Related Protein Kinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Cell Division Cycle 7 Related Protein Kinase Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Cell Division Cycle 7 Related Protein Kinase Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • LBS-007
  • LY-3143921
  • MSK-777
  • TAK-931
  • Others
Applications
  • Metastatic Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Acute Myelocytic Leukemia
  • Others
Companies covered
  • Millennium Pharmaceuticals Inc
  • Nerviano Medical Sciences Srl
  • Sierra Oncology Inc
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cell Division Cycle 7 Related Protein Kinase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cell Division Cycle 7 Related Protein Kinase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cell Division Cycle 7 Related Protein Kinase Market by Type
  6. 1.3.1 LBS-007
  7. 1.3.2 LY-3143921
  8. 1.3.3 MSK-777
  9. 1.3.4 TAK-931
  10. 1.3.5 Others
  11. 1.4 Global Cell Division Cycle 7 Related Protein Kinase Market Size by Type
  12. 1.4.1 Global Cell Division Cycle 7 Related Protein Kinase Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Cell Division Cycle 7 Related Protein Kinase Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Cell Division Cycle 7 Related Protein Kinase Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cell Division Cycle 7 Related Protein Kinase Industry Trends
  2. 2.2 Cell Division Cycle 7 Related Protein Kinase Industry Drivers
  3. 2.3 Cell Division Cycle 7 Related Protein Kinase Industry Opportunities and Challenges
  4. 2.4 Cell Division Cycle 7 Related Protein Kinase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cell Division Cycle 7 Related Protein Kinase Revenue (2021-2026)
  2. 3.2 Global Top Players by Cell Division Cycle 7 Related Protein Kinase Sales (2021-2026)
  3. 3.3 Global Top Players by Cell Division Cycle 7 Related Protein Kinase Price (2021-2026)
  4. 3.4 Global Cell Division Cycle 7 Related Protein Kinase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cell Division Cycle 7 Related Protein Kinase Major Company Production Sites & Headquarters
  6. 3.6 Global Cell Division Cycle 7 Related Protein Kinase Company, Product Type & Application
  7. 3.7 Global Cell Division Cycle 7 Related Protein Kinase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cell Division Cycle 7 Related Protein Kinase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cell Division Cycle 7 Related Protein Kinase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cell Division Cycle 7 Related Protein Kinase Tier 1, Tier 2, and Tier 3
4 Cell Division Cycle 7 Related Protein Kinase Regional Status and Outlook
  1. 4.1 Global Cell Division Cycle 7 Related Protein Kinase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cell Division Cycle 7 Related Protein Kinase Historic Market Size by Region
  3. 4.2.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cell Division Cycle 7 Related Protein Kinase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cell Division Cycle 7 Related Protein Kinase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cell Division Cycle 7 Related Protein Kinase Forecasted Market Size by Region
  7. 4.3.1 Global Cell Division Cycle 7 Related Protein Kinase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cell Division Cycle 7 Related Protein Kinase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cell Division Cycle 7 Related Protein Kinase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cell Division Cycle 7 Related Protein Kinase by Application
  1. 5.1 Cell Division Cycle 7 Related Protein Kinase Market by Application
  2. 5.1.1 Metastatic Breast Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Colorectal Cancer
  5. 5.1.4 Acute Myelocytic Leukemia
  6. 5.1.5 Others
  7. 5.2 Global Cell Division Cycle 7 Related Protein Kinase Market Size by Application
  8. 5.2.1 Global Cell Division Cycle 7 Related Protein Kinase Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Cell Division Cycle 7 Related Protein Kinase Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Cell Division Cycle 7 Related Protein Kinase Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Millennium Pharmaceuticals Inc
  2. 6.1.1 Millennium Pharmaceuticals Inc Company Information
  3. 6.1.2 Millennium Pharmaceuticals Inc Business Overview
  4. 6.1.3 Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Millennium Pharmaceuticals Inc Cell Division Cycle 7 Related Protein Kinase Product Portfolio
  6. 6.1.5 Millennium Pharmaceuticals Inc Recent Developments
  7. 6.2 Nerviano Medical Sciences Srl
  8. 6.2.1 Nerviano Medical Sciences Srl Company Information
  9. 6.2.2 Nerviano Medical Sciences Srl Business Overview
  10. 6.2.3 Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nerviano Medical Sciences Srl Cell Division Cycle 7 Related Protein Kinase Product Portfolio
  12. 6.2.5 Nerviano Medical Sciences Srl Recent Developments
  13. 6.3 Sierra Oncology Inc
  14. 6.3.1 Sierra Oncology Inc Company Information
  15. 6.3.2 Sierra Oncology Inc Business Overview
  16. 6.3.3 Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sierra Oncology Inc Cell Division Cycle 7 Related Protein Kinase Product Portfolio
  18. 6.3.5 Sierra Oncology Inc Recent Developments
  19. 6.4 Eli Lilly and Company
  20. 6.4.1 Eli Lilly and Company Company Information
  21. 6.4.2 Eli Lilly and Company Business Overview
  22. 6.4.3 Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly and Company Cell Division Cycle 7 Related Protein Kinase Product Portfolio
  24. 6.4.5 Eli Lilly and Company Recent Developments
  25. 6.5 Takeda Pharmaceutical Company Ltd
  26. 6.5.1 Takeda Pharmaceutical Company Ltd Company Information
  27. 6.5.2 Takeda Pharmaceutical Company Ltd Business Overview
  28. 6.5.3 Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Takeda Pharmaceutical Company Ltd Cell Division Cycle 7 Related Protein Kinase Product Portfolio
  30. 6.5.5 Takeda Pharmaceutical Company Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Cell Division Cycle 7 Related Protein Kinase Sales by Country
  2. 7.1.1 North America Cell Division Cycle 7 Related Protein Kinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026)
  4. 7.1.3 North America Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cell Division Cycle 7 Related Protein Kinase Market Size by Country
  6. 7.2.1 North America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026)
  8. 7.2.3 North America Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cell Division Cycle 7 Related Protein Kinase Sales by Country
  2. 8.1.1 Europe Cell Division Cycle 7 Related Protein Kinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026)
  4. 8.1.3 Europe Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cell Division Cycle 7 Related Protein Kinase Market Size by Country
  6. 8.2.1 Europe Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Country
  2. 9.1.1 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size by Country
  6. 9.2.1 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cell Division Cycle 7 Related Protein Kinase Sales by Country
  2. 10.1.1 South America Cell Division Cycle 7 Related Protein Kinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026)
  4. 10.1.3 South America Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cell Division Cycle 7 Related Protein Kinase Market Size by Country
  6. 10.2.1 South America Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026)
  8. 10.2.3 South America Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Country
  2. 11.1.1 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size by Country
  6. 11.2.1 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cell Division Cycle 7 Related Protein Kinase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cell Division Cycle 7 Related Protein Kinase Value Chain Analysis
  2. 12.1.1 Cell Division Cycle 7 Related Protein Kinase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cell Division Cycle 7 Related Protein Kinase Production Mode & Process
  7. 12.2 Cell Division Cycle 7 Related Protein Kinase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cell Division Cycle 7 Related Protein Kinase Distributors
  10. 12.2.3 Cell Division Cycle 7 Related Protein Kinase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst